VERVE THERAPEUTICS INC

CUSIP: 92539P101 Class: Common Stock

WELLINGTON MANAGEMENT GROUP LLP's Holding History (CIK: 0000902219)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 298,688 Value ($000) $3,354 Avg Close — Range —
Q1 2025
Shares 244,183 Value ($000) $1,116 Avg Close — Range —
Q4 2024
Shares 361,498 Value ($000) $2,039 Avg Close — Range —
Q3 2024
Shares 347,029 Value ($000) $1,680 Avg Close — Range —
Q2 2024
Shares 371,300 Value ($000) $1,812 Avg Close — Range —
Q1 2024
Shares 253,034 Value ($000) $3,360 Avg Close — Range —
Q4 2023
Shares 157,241 Value ($000) $2,192 Avg Close — Range —
Q3 2023
Shares 792,526 Value ($000) $10,509 Avg Close — Range —
Q2 2023
Shares 976,128 Value ($000) $18,302 Avg Close — Range —
Q1 2023
Shares 933,167 Value ($000) $13,456 Avg Close — Range —
Q4 2022
Shares 859,102 Value ($000) $16,624 Avg Close — Range —
Q3 2022
Shares 1,010,708 Value ($000) $34,718 Avg Close — Range —
Q2 2022
Shares 1,263,384 Value ($000) $19,305 Avg Close — Range —
Q1 2022
Shares 2,346,047 Value ($000) $53,538 Avg Close — Range —
Q4 2021
Shares 3,939,508 Value ($000) $145,251 Avg Close — Range —
Q3 2021
Shares 4,594,226 Value ($000) $213,551 Avg Close — Range —
Q2 2021
Shares 3,965,479 Value ($000) $232,082 Avg Close — Range —